Herb-drug interactions: A short review on central and peripheral nervous system drugs

被引:1
作者
Bernardo, Joao [1 ]
Valentao, Patricia [1 ]
机构
[1] Univ Porto, Fac Farm, Dept Quim, REQUIMTE LAQV,Lab Farmacognosia, Rua Jorge Viterbo Ferreira 228, P-4050313 Porto, Portugal
关键词
central nervous system drugs; herb-drug interactions; medicinal plants; peripheral nervous system medications; pharmacodynamics; pharmacokinetics; ST-JOHNS-WORT; GINKGO-BILOBA EXTRACT; KAVA PIPER-METHYSTICUM; GRAPEFRUIT JUICE; IN-VITRO; CYTOCHROME-P450; ACTIVITY; ORAL BIOAVAILABILITY; WESTERN MEDICINES; P-GLYCOPROTEIN; DOUBLE-BLIND;
D O I
10.1002/ptr.8120
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Herbal medicines are widely perceived as natural and safe remedies. However, their concomitant use with prescribed drugs is a common practice, often undertaken without full awareness of the potential risks and frequently without medical supervision. This practice introduces a tangible risk of herb-drug interactions, which can manifest as a spectrum of consequences, ranging from acute, self-limited reactions to unpredictable and potentially lethal scenarios. This review offers a comprehensive overview of herb-drug interactions, with a specific focus on medications targeting the Central and Peripheral Nervous Systems. Our work draws upon a broad range of evidence, encompassing preclinical data, animal studies, and clinical case reports. We delve into the intricate pharmacodynamics and pharmacokinetics underpinning each interaction, elucidating the mechanisms through which these interactions occur. One pressing issue that emerges from this analysis is the need for updated guidelines and sustained pharmacovigilance efforts. The topic of herb-drug interactions often escapes the attention of both consumers and healthcare professionals. To ensure patient safety and informed decision-making, it is imperative that we address this knowledge gap and establish a framework for continued monitoring and education. In conclusion, the use of herbal remedies alongside conventional medications is a practice replete with potential hazards. This review not only underscores the real and significant risks associated with herb-drug interactions but also underscores the necessity for greater awareness, research, and vigilant oversight in this often-overlooked domain of healthcare.
引用
收藏
页码:1903 / 1931
页数:29
相关论文
共 243 条
[11]   The effects of oral administration of Cola nitida on the pharmacokinetic profile of metoclopramide in rabbits [J].
Amadi, Cecilia Nwadiuto ;
Nwachukwu, Wisdom Izuchukwu .
BMC PHARMACOLOGY & TOXICOLOGY, 2020, 21 (01)
[12]   Herbal medicines in children with attention deficit hyperactivity disorder (ADHD): A systematic review [J].
Anheyer, Dennis ;
Lauche, Romy ;
Schumann, Dania ;
Dobos, Gustav ;
Cramer, Holger .
COMPLEMENTARY THERAPIES IN MEDICINE, 2017, 30 :14-23
[13]   Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.) [J].
Anke, J ;
Ramzan, I .
JOURNAL OF ETHNOPHARMACOLOGY, 2004, 93 (2-3) :153-160
[14]  
[Anonymous], 2000, General guidelines for methodologies on research and evaluation of traditional medicine
[15]  
[Anonymous], 2013, WHO TRADITIONAL MED
[16]   Identification of Novel Metoclopramide Metabolites in Humans: In Vitro and In Vivo Studies [J].
Argikar, Upendra A. ;
Gomez, Javier ;
Ung, Din ;
Parkman, Henry P. ;
Nagar, Swati .
DRUG METABOLISM AND DISPOSITION, 2010, 38 (08) :1295-1307
[17]   No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract [J].
Arold, G ;
Donath, F ;
Maurer, A ;
Diefenbach, K ;
Bauer, S ;
Henneicke-von Zepelin, HH ;
Friede, M ;
Roots, I .
PLANTA MEDICA, 2005, 71 (04) :331-337
[18]   Enhanced Oral Bioavailability of Domperidone with Piperine in Male Wistar Rats: Involvement of CYP3A1 and P-gp Inhibition [J].
Athukuri, Bhargavi Latha ;
Neerati, Prasad .
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2017, 20 (01) :28-37
[19]   Interactions between grapefruit juice and cardiovascular drugs [J].
Bailey D.G. ;
Dresser G.K. .
American Journal of Cardiovascular Drugs, 2004, 4 (5) :281-297
[20]  
Bajwa Sukhminder Jit Singh, 2012, Ayu, V33, P475, DOI 10.4103/0974-8520.110515